Daglupa Met 5/500 Tablet ER

Overview Daglupa Met 5/500 Tablet ER

Metformin/Glimepiride 5/500mg Extended-Release tablets manage type 2 diabetes by regulating elevated blood glucose. This control lessens the risk of severe diabetic complications and contributes to heart health prevention. Consume this medication with food, consistently at the same time daily for optimal adherence. Dosage is determined by your physician; discontinuation requires their consultation, as abrupt cessation can elevate blood sugar, potentially leading to kidney issues or vision impairment. This medication complements a comprehensive diabetes plan encompassing diet, exercise, and weight management as directed by your doctor. Common side effects include throat irritation, nasal stuffiness, rhinorrhea, headache, nausea, emesis, and diarrhea. Hydration is crucial to mitigate dehydration. Genital yeast infections are a potential side effect; diligent hygiene can reduce this risk. Prior to commencement, disclose kidney or liver disease, urinary tract infections, or diuretic use to your physician. Pregnant or lactating individuals should seek medical advice before use. Limit alcohol consumption to minimize potential side effects. Regular blood glucose monitoring is essential during treatment.

Primary Ingredients of Daglupa Met 5/500 Tablet ER

The provided text is "undefined," offering no content to rephrase. Therefore, no rewritten text can be provided.

Uses of Daglupa Met 5/500 Tablet ER

Managing type 2 diabetes

Major Benefits of Daglupa Met 5/500 Tablet ER:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Daglupa Met 5/500 Extended-Release Tablets should be administered with a meal.

Common Side effects of Daglupa Met 5/500 Tablet ER:

• Nausea
• Vomiting
• Diarrhea
• Genital fungal infection
• Nasopharyngitis (inflammation of the throat and nasal passages)
• Urinary tract infection
• Polyuria
• Flatulence
• Skin rash
• Taste change
• Difficulty in urination
• Hypoglycemia (low blood glucose level)
• Tremors
• Dizziness
• Back pain
• Increased hematocrit
• Decreased creatinine clearance
• Dyslipidemia

How to use Daglupa Met 5/500 Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Daglupa Met 5/500 Tablet ER should be administered with a meal.

How Daglupa Met 5/500 Tablet ER works:

The extended-release Daglupa Met 5/500 tablet combines dapagliflozin and metformin to manage blood glucose. Dapagliflozin facilitates urinary glucose excretion, while metformin reduces hepatic glucose output, slows intestinal glucose uptake, and enhances insulin responsiveness. This dual action optimizes blood sugar regulation.

What if you forget to take Daglupa Met 5/500 Tablet ER :

Should you forget a Daglupa Met 5/500 Tablet ER dose, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.